23.32 USD
-0.54 (-2.26%)
23.32 USD
0 (0%)
Taking everything into account, PRVA scores 4 out of 10 in our fundamental rating. PRVA was compared to 102 industry peers in the Health Care Providers & Services industry. PRVA has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, PRVA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year PRVA was profitable.
- In the past year PRVA had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
- In the past 5 years PRVA always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of 1.34%, PRVA perfoms like the industry average, outperforming 53.92% of the companies in the same industry.
- With a Return On Equity value of 2.56%, PRVA perfoms like the industry average, outperforming 57.84% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 2.45%, PRVA is in line with its industry, outperforming 48.04% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PRVA has a Profit Margin (0.89%) which is in line with its industry peers.
- PRVA's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 1.38%, PRVA is in line with its industry, outperforming 46.08% of the companies in the same industry.
- PRVA's Operating Margin has declined in the last couple of years.
- PRVA has a worse Gross Margin (10.17%) than 73.53% of its industry peers.
- In the last couple of years the Gross Margin of PRVA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
- PRVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, PRVA has more shares outstanding
- The number of shares outstanding for PRVA has been increased compared to 5 years ago.
- There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 4.44 indicates that PRVA is not in any danger for bankruptcy at the moment.
- The Altman-Z score of PRVA (4.44) is better than 80.39% of its industry peers.
- There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.44 |
ROIC/WACC0.28
WACC8.92%
2.3 Liquidity
- A Current Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
- With a decent Current ratio value of 1.67, PRVA is doing good in the industry, outperforming 64.71% of the companies in the same industry.
- PRVA has a Quick Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
- PRVA's Quick ratio of 1.67 is fine compared to the rest of the industry. PRVA outperforms 69.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
- PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
- Measured over the past 5 years, PRVA shows a small growth in Earnings Per Share. The EPS has been growing by 7.43% on average per year.
- The Revenue has grown by 19.01% in the past year. This is quite good.
- The Revenue has been growing by 17.17% on average over the past years. This is quite good.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
3.2 Future
- The Earnings Per Share is expected to grow by 69.05% on average over the next years. This is a very strong growth
- Based on estimates for the next years, PRVA will show a small growth in Revenue. The Revenue will grow by 2.73% on average per year.
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.05%
EPS Next 5YN/A
Revenue Next Year20.24%
Revenue Next 2Y15.2%
Revenue Next 3Y13.5%
Revenue Next 5Y2.73%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 179.38 indicates a quite expensive valuation of PRVA.
- Compared to the rest of the industry, the Price/Earnings ratio of PRVA is on the same level as its industry peers.
- When comparing the Price/Earnings ratio of PRVA to the average of the S&P500 Index (27.38), we can say PRVA is valued expensively.
- Based on the Price/Forward Earnings ratio of 72.78, the valuation of PRVA can be described as expensive.
- PRVA's Price/Forward Earnings ratio is in line with the industry average.
- When comparing the Price/Forward Earnings ratio of PRVA to the average of the S&P500 Index (24.29), we can say PRVA is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 179.38 | ||
| Fwd PE | 72.78 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, PRVA is valued a bit more expensive than the industry average as 61.76% of the companies are valued more cheaply.
- PRVA's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.91 | ||
| EV/EBITDA | 65.09 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRVA does not grow enough to justify the current Price/Earnings ratio.
- A more expensive valuation may be justified as PRVA's earnings are expected to grow with 69.05% in the coming years.
PEG (NY)8.15
PEG (5Y)24.13
EPS Next 2Y70.67%
EPS Next 3Y69.05%
5. Dividend
5.1 Amount
- PRVA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
23.32
-0.54 (-2.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners98.68%
Inst Owner Change0.02%
Ins Owners1.85%
Ins Owner Change0%
Market Cap2.87B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.44
Price Target32.18 (37.99%)
Short Float %2.62%
Short Ratio4.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)0.48%
PT rev (3m)3.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.32%
Revenue NQ rev (1m)-28.31%
Revenue NQ rev (3m)-22.56%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)4.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 179.38 | ||
| Fwd PE | 72.78 | ||
| P/S | 1.4 | ||
| P/FCF | 25.91 | ||
| P/OCF | 25.91 | ||
| P/B | 4.04 | ||
| P/tB | 7.77 | ||
| EV/EBITDA | 65.09 |
EPS(TTM)0.13
EY0.56%
EPS(NY)0.32
Fwd EY1.37%
FCF(TTM)0.9
FCFY3.86%
OCF(TTM)0.9
OCFY3.86%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)8.15
PEG (5Y)24.13
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.44 |
F-Score7
WACC8.92%
ROIC/WACC0.28
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.05%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year20.24%
Revenue Next 2Y15.2%
Revenue Next 3Y13.5%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.2%
EBIT Next 3Y111.25%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
Can you provide the valuation status for PRIVIA HEALTH GROUP INC?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for PRVA stock?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 179.38 and the Price/Book (PB) ratio is 4.04.
Can you provide the financial health for PRVA stock?
The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.